Hubei Guangji Pharmaceutical Co., Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 794.85 million compared to CNY 785.1 million a year ago. Revenue was CNY 797.64 million compared to CNY 785.57 million a year ago.

Net income was CNY 50.37 million compared to CNY 110.11 million a year ago. Basic earnings per share from continuing operations was CNY 0.1434 compared to CNY 0.3201 a year ago. Diluted earnings per share from continuing operations was CNY 0.1428 compared to CNY 0.3201 a year ago.